A Long-term, Randomized, Open-labeled, Parallel-group Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 10 Aug 2013
At a glance
- Drugs Liraglutide (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- Acronyms ADELANTE
- 10 Jun 2017 Biomarkers information updated
- 01 Jul 2013 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 19 May 2012 Actual initiation date 23 Apr 2012 added as reported by European Clinical Trials Database.